Null mutation in SCN9A in which noxious stimuli can be detected in the absence of pain

The term nociception was originally defined by Sherrington1 as the neural process by which high-threshold stimuli (which cause tissue injury) are detected. This is distinct from pain, which is defined by the quality of the sensory percept (i.e., unpleasant), is not always evoked by a noxious stimulus, and can also be experienced in the absence of a noxious stimulus. In man, recessive loss of function mutations in the SCN9A gene, encoding the α subunit of Nav1.7, results in anosmia and the congenital inability to experience pain,2–4 but there have been few reports of detailed sensory testing in these patients.


NULL MUTATION IN SCN9A IN WHICH NOXIOUS STIMULI CAN BE DETECTED IN THE ABSENCE OF PAIN
The term nociception was originally defined by Sherrington 1 as the neural process by which high-threshold stimuli (which cause tissue injury) are detected. This is distinct from pain, which is defined by the quality of the sensory percept (i.e., unpleasant), is not always evoked by a noxious stimulus, and can also be experienced in the absence of a noxious stimulus. In man, recessive loss of function mutations in the SCN9A gene, encoding the a subunit of Na v 1.7, results in anosmia and the congenital inability to experience pain, 2-4 but there have been few reports of detailed sensory testing in these patients.
Case report. A 27-year-old man who participated in the Painful Channelopathies Study (NRES-UK reference: 12/LO/0017) had a history of selfmutilating behavior during childhood and multiple painless injuries with normal cognitive development. He had never perceived pain but reported that otherwise somatosensation was normal. In his late teens, he learned to avoid injury by attending to what he described as a tingling sensation, which was not unpleasant but that he noted only occurred in the context of threatened tissue injury. The family pedigree is shown in the figure, A. He had 2 sisters, one of whom died in childhood as a consequence of sepsis. The surviving sister also has congenital inability to experience pain.
The proband presented with short stature of 149 cm. He was anosmic. Tone and power were normal throughout and all deep tendon reflexes were preserved. He had no impairment in light touch, vibration detection, or proprioception. Pinprick was not perceived as painful although he could detect that it was pointed and a flare developed shortly after stimulation.
Genetic testing for SCN9A mutations in the index case and his sister ( studies demonstrated small-amplitude sural sensory nerve action potentials (table e-1 on the Neurology ® Web site at Neurology.org). Quantitative sensory testing was performed according to the German Neuropathic Pain Network 5 (e-Methods). He did not experience pain (i.e., there was no unpleasant sensation) in response to any stimulus applied including extremes of temperature or mechanical stimuli. His mechanical detection and vibration detection thresholds were normal. He was hyposensitive to warm and cool stimuli (figure, C). High temperatures and strong mechanical stimuli evoked a mild tingling sensation. This sensation was never unpleasant but he had learned to use it as an injury signal. We therefore performed suprathreshold thermal stimulation by giving randomized thermal stimuli and asking him to rate the intensity of this sensation ( figure, D). The threshold for this stimulus was in the noxious range at 42°C and the intensity of the sensation could encode the strength of the stimulus. Skin biopsy taken from the distal leg showed that intraepidermal nerve fibers were present although at a density below the lower limit of normal (figure, E).
Discussion. The index case reported in this kindred demonstrated insensitivity to pain, normal large-fiber sensory function, and anosmia: typical features of congenital insensitivity to pain (CIP) secondary to SCN9A mutations. Genetic testing revealed compound heterozygous mutations in SCN9A: a premature stop codon in coding exon 15 (c.2488C.T), which has previously been reported, 3 and a previously unreported 1-bp deletion within coding exon 26 (c.5318delA), which induces a frameshift at position 1773 in the C-terminal domain of the channel. The patient had identified a sensation that was not unpleasant but only occurred in the context of strong mechanical or thermal stimuli that could cause tissue injury. The sensation was mild, localized to the stimulus, and had a tingling quality to it. He used this sensation as a warning signal and had managed to reduce the frequency of injury. It is currently unclear as to the mechanism by which he can detect tissue injury in the absence of pain. Nociceptors still innervate the skin, albeit at a lower density than in agematched controls. The proposed mechanisms through which null mutations in Na v 1.7 result in inability to experience pain include impaired transduction in nociceptor terminals, action potential transmission along the axon, and release of neurotransmitter from central terminals of sensory afferents. 6,7 It is possible that a small population of nociceptive afferents are able to function in the absence of Na v 1.7 but provide insufficient input to drive pain sensation. This case further emphasizes that the detection of noxious stimuli and the sensation of pain are distinct and could also have practical implications if other patients with CIP can train themselves to attend to sensations that may indicate potential tissue injury but are not painful.